Legend Biotech (LEGN) Prepaid Assets (2019 - 2025)
Legend Biotech (LEGN) posted Prepaid Assets of $253.4 million for Q4 2025, up 15.71% on a QoQ basis from $219.0 million in Q3 2025, and up 93.44% year-over-year from $131.0 million in Q4 2024.
Legend Biotech (LEGN) Prepaid Assets (2019 - 2025) Analysis & Trends
Legend Biotech's Prepaid Assets history runs 7 years deep, the most recent figure standing at $253.4 million for Q4 2025.
- Quarterly Prepaid Assets rose 93.44% year-over-year to $253.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $253.4 million (up 93.44% YoY) and the FY2025 annual result came in at $253.4 million, up 93.44% from the prior year.
- Prepaid Assets was $253.4 million for Q4 2025 at Legend Biotech, up from $219.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $253.4 million in Q4 2025 and bottomed at $10425.0 in Q1 2021.
- A 5-year average of $89.2 million and a median of $67.9 million in 2023 frame the typical range for Prepaid Assets.
- Peak annual rise in Prepaid Assets reached 183132.61% in 2022, while the deepest fall reached 92.12% in 2022.
- Legend Biotech's Prepaid Assets stood at $13.9 million in 2021, then tumbled by 92.12% to $1.1 million in 2022, then soared by 6241.67% to $69.3 million in 2023, then jumped by 89.17% to $131.0 million in 2024, then soared by 93.44% to $253.4 million in 2025.
- Business Quant data shows LEGN's Prepaid Assets at $253.4 million in Q4 2025, $219.0 million in Q3 2025, and $219.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 253.40 Mn |
| Sep 30, 2025 | 218.99 Mn |
| Jun 30, 2025 | 219.08 Mn |
| Mar 31, 2025 | 182.04 Mn |
| Dec 31, 2024 | 131.00 Mn |
| Sep 30, 2024 | 112.80 Mn |
| Jun 30, 2024 | 100.63 Mn |
| Mar 31, 2024 | 85.60 Mn |
| Dec 31, 2023 | 69.25 Mn |
| Sep 30, 2023 | 66.57 Mn |
| Jun 30, 2023 | 66.57 Mn |
| Mar 31, 2023 | 51.76 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Mar 31, 2022 | 19.10 Mn |
| Dec 31, 2021 | 13.85 Mn |
| Sep 30, 2021 | 13.84 Mn |
| Jun 30, 2021 | 11,170.00 |
| Mar 31, 2021 | 10,425.00 |
| Dec 31, 2020 | 10.45 Mn |
| Sep 30, 2020 | 24,662.00 |